Background illustration for clinical trials search

Endocrine Clinical Trials

Browse 341 endocrine clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Location: New Haven CT
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT06917313

Phase2, Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

for
Obesity and Obesity-related Medical Conditions, Diabetes,
Location: Columbia MO
Sponsor: Bettina Mittendorfer

Sex: All

Age: 18 - 70+

Code: NCT07083557

Recruiting

Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

for
Breast Cancer Females
Location: Toronto
Sponsor: University of Toronto

Sex: Female

Age: 0+

Code: NCT06781762

Recruiting

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

for
HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer
Location: New York NY, Sarasota FL, Houston TX, New Haven CT,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06998407

Phase1, Phase2, Recruiting

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 60+

Code: NCT06897488

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy

for
HER2 Negative Breast Cancer
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT06953882

Phase2, Recruiting

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

for
Breast Cancer, Early Breast Cancer
Location: Winston-Salem NC, Irving TX, Aberdeen SD, Pierre SD
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05774951

Phase3, Recruiting

Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Boston MA, Stony Brook NY, Mineola NY, New York NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06380751

Phase3, Recruiting

Observation of Environment and Reproductive-Endocrine Effects

for
Hypogonadism, Hypergonadism, Precocious Puberty, Late Puberty,
Location: Research Triangle Park NC
Sponsor: National Institute of Environmental Health Sciences (NIEHS)

Sex: All

Age: 8 - 70+

Code: NCT06280807

Recruiting

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

for
Thyroid, PD-1, Cancer
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT04615988

Recruiting

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

for
Advanced HR+/HER2- Breast Cancer
Location: New Haven CT, Toronto, Dallas TX
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07604571

Phase1, Recruiting

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

for
Early-stage Breast Cancer,
Location: Boston MA, Wichita KS, Fullerton CA, Whittier CA,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04553770

Phase2, Recruiting

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

for
Anatomic Stage III Breast Cancer AJCC v8,
Location: Boston MA, St Louis MO
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07137416

Phase1, Recruiting

Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer

for
Hormone Receptor-positive Breast Cancer,
Location: Boston MA, Fairfax VA, Tampa FL, Detroit MI,
Sponsor: Ellipses Pharma

Sex: Female

Age: 18+

Code: NCT05573126

Phase1, Phase2, Recruiting

Registry for Adults With Plasma Cell Disorders (PCD's)

for
Multiple Myeloma, Amyloidosis, Cryoglobulinemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT03717844

Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for
Small Cell Lung Cancer (SCLC ),
Location: New York NY, Hackensack NJ, Nashville TN, St Louis MO,
Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase1, Recruiting

A Clinical Trial to Evaluate the Effects of a Powder Supplement in Supporting Lean Muscle Development, Hormone-Related Wellness, Digestive Comfort, Dermatologic Health, and Overall Wellness

for
Lean Muscle Development, Muscular Endurance,
Location: Las Vegas NV
Sponsor: Clean Nutraceuticals

Sex: All

Age: 21 - 45

Code: NCT07766395

Recruiting

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

for
Gastroenteropancreatic Neuroendocrine Tumor
Location: East Hanover NJ
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07635316

Recruiting

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

for
Neuroendocrine Carcinoma, Neuroendocrine Tumors
Location: Miami FL
Sponsor: Peter Hosein, MD

Sex: All

Age: 18+

Code: NCT06889493

Phase1, Recruiting

Fatigue, Sleep Disorders and Endocrine Abnormalities in TBI Patients

for
Traumatic Brain Injury
Location: West Orange NJ
Sponsor: Kessler Foundation

Sex: All

Age: 18 - 70

Code: NCT00775775

Recruiting